Noveko Announces the Launch of its New Microban(R) Line of Hand Sanitizers and Access to more than 8,000 points of sale in Canada

Noveko International Inc. ("the Company") is pleased to announce the launch of its new Microban(R) line of hand sanitizers. The hand sanitizers formerly marketed under the AZURO(TM) brand are now sold under the Microban(R) brand name, pursuant to the terms of the August 2009 agreement with Microban International, Ltd. ("Microban"), the global leader in built-in antimicrobial product protection.

"We are very proud of this strategic milestone in the market development of our hand sanitizers. The Microban(R) brand is recognized around the world as a guarantee of effective, durable antimicrobial protection.

The reputation of the Microban(R) brand used on over 750 products worldwide, combined with the high-performance antimicrobial properties of our products, which kill 99.9% of common germs on contact thanks to 70% to 80% alcohol concentrations, will enable to further penetrate the different segments of the institutional and retail markets on a global scale," indicated Alain Bolduc, President and Chief Operating Officer of the Company.

Production of the various AZURO(TM) hand sanitizer formats has been replaced by the production of Microban(R) hand sanitizers. These use the same quality formula as formerly and will gradually replace the AZURO(TM) products. The new Microban(R) line of hand sanitizers also includes two new 60 ml and 250 ml formats.

The activities related to Noveko Inc.'s sanitizers achieved major breakthroughs during fiscal 2009, especially in the high-potential hospital and institutional segments. Today, whereas the population is further aware of the importance and benefits associated with the proper use of sanitizers in maintaining good hand hygiene, the Company is also pleased to announce that it is intensifying the marketing of its hand sanitizers on a wider scale, making them available to the population at large. Microban(R) hand sanitizers will be sold by several Canadian leaders in the food and drug retail markets, such as Shoppers Drug Mart/Pharmaprix, the Jean Coutu Group (PJC) Inc., the Brunet pharmacies, the Rexall pharmacies of Katz Group Canada Ltd., the Safeway supermarkets as well as the Metro Inc. supermarkets and grocery stores. McMahon Distributeur pharmaceutique Inc. and Mc Kesson Canada will also distribute the Microban(R) hand sanitizers in the retail market.

"We are particularly pleased with the milestones achieved in marketing our line of hand sanitizers and broadening our client base. We now have access to more than 8,000 points of sale in Canada and we are focused on further developing on markets in that regard," added Mr. Bolduc.

Profile

Noveko International Inc. offers innovative solutions in the environmental and medical fields worldwide. Through its subsidiaries, the Company specializes primarily in the following business segments: the development, manufacturing and marketing of derivative products from its patented antimicrobial filtration technology, including air filters, surgical masks and respirators, along with other products with antimicrobial properties such as Microban(R) hand sanitizers - and the development, manufacturing and marketing of medical equipment, primarily portable real-time ultrasound scanners for use in human and veterinary medicine.

Certain statements set forth in this press release constitute forward-looking statements. In some cases, these statements are identified by the use of terms such as "may", "could", "might", "intend", "should", "expect", "project", "plan", "believe", "estimate" or other comparable variants. These statements are based on the information available at the time they are written, on assumptions made by management and on the expectations of management, acting in good faith, regarding future events, including those relating to economic conditions, fluctuations in exchange rates and operating expenses, and the absence of unusual events entailing supplementary expenditures. Although management considers these assumptions and expectations reasonable based on the information available at the time they are written, they could prove inaccurate. Forward-looking statements are also subject, by their very nature, to known and unknown risks and uncertainties such as those related to the industry, acquisitions, labor relations, credit, key officers, supply and product liability. The actual results of Noveko International Inc. could differ materially from those indicated or underlying these forward-looking statements. The reader is therefore recommended not to unduly rely on these forward-looking statements. Forward-looking statements do not reflect the potential impact of special items, any business combination or any other transaction that may be announced or occur subsequent to the date hereof. Unless otherwise required under securities laws, the Company does not intend and undertakes no obligation to update or revise the forward-looking statements to account for new information, new events or new circumstances.

Contacts

Chantal Vennat
Director
Investor Relations and Corporate Communications
Noveko International Inc.
(514) 875-0606
http://www.noveko.com